medical biotechnologyCAR T-Cell Therapy is About to Become Available in EuropeCAR T-Cell Therapy is About to Become Available in Europe The European Medicines Agency has recommended the approval of what could soon be the first two CAR T-cell therapies for cancer in Europe. At its latest meeting, the EMA’s Committee for Medicinal Products for Human Use (CHMP) recommended the approval of Kymriah and Yescarta. Both are CAR-T therapies, a form …ادامه مطلب
medical biotechnologyASH: Anti-CD19 CAR T-cell Tx beneficial in B-cell lymphomas(HealthDay)—Axicabtagene ciloleucel (axi-cel), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy and autologous T cells that express a CD19-directed CAR (CTL019) are effective for refractory B-cell lymphomas, according to two studies published online Dec. 10 in the New England Journal of Medicine to coincide with the annual meeting of the American Society of Hematology, held from Dec. 9 to 12 in …ادامه مطلب
